Inozyme Pharma, Inc. (INZY) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Inozyme Pharma, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Inozyme Pharma, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $88.9 M, a 42.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $88.9 M +$26.4 M +42.3% Dec 31, 2023 10-K 2024-03-12
Q4 2022 $62.5 M +$20.4 M +48.5% Dec 31, 2022 10-K 2024-03-12
Q4 2021 $42.1 M +$17.9 M +73.8% Dec 31, 2021 10-K 2023-03-22
Q4 2020 $24.2 M +$14.9 M +160% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $9.32 M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.